Clarity Pharmaceuticals has an EPS of $-0.095. In 2022, the company made an earnings per share (EPS) of $-0.096. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$0.095 | -1.04% |
2022 | -$0.096 | - |